Casdin Partners GP, LLC 4
4 · GeneDx Holdings Corp. · Filed Aug 22, 2025
Insider Transaction Report
Form 4
Casdin Capital, LLC
Director10% Owner
Transactions
- Sale
Class A Common Stock
2025-08-22$120.90/sh−500,000$60,451,950→ 3,007,164 total(indirect: See footnote)
Holdings
- 20,518
Class A Common Stock
- 333,144(indirect: See footnote)
Class A Common Stock
- 19,247(indirect: See footnote)
Class A Common Stock
Footnotes (4)
- [F1]The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F2]The securities are owned directly by Eli Casdin.
- [F3]The securities are owned directly by the GP and may be deemed to be indirectly beneficially owned by Eli Casdin, the managing member of the GP.
- [F4]The securities are owned directly by CMLS Holdings LLC ("CMLS Holdings"). The Board of Managers of CMLS Holdings includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings, shares voting and investment discretion with respect to the common stock held by CMLS Holdings.